$120.85$150.99
Prepare to embark on a sensory journey with the Bosco Apple, a fruit that transcends the ordinary and promises an unparalleled taste experience. These apples are nothing short of nature’s masterpiece, celebrated for their distinctive blend of flavors and their captivating visual allure.
Availability: In Stock
Subscribe to out newsletter today to receive latest news administrate cost effective for tactical data.
₹274
INTRODUCTION LATOBEST OPHTHALMIC SOLUTION contains Latanoprost which belongs to the group of medicines called Prostaglandin analogs. It is used to treat open angle glaucoma and ocular hypertension (both linked to increased pressure in the eye). Glaucoma is a group of diseases characterized by...
LATOBEST OPHTHALMIC SOLUTION contains Latanoprost which belongs to the group of medicines called Prostaglandin analogs. It is used to treat open angle glaucoma and ocular hypertension (both linked to increased pressure in the eye). Glaucoma is a group of diseases characterized by gradual damage to the optic nerve (nerves that carry visual messages), that may result in loss of vision. Prior to the treatment, your doctor may want you to take certain eye tests to understand your existing condition.
Before using LATOBEST OPHTHALMIC SOLUTION, inform your doctor if you or your child have eye problems (pain, irritation or inflammation of eyes, blurred vision or dry eyes) or viral infection of the eye. Also inform your doctor if you have severe asthma, are using contact lens or going to have an eye surgery (cataract surgery).
LATOBEST OPHTHALMIC SOLUTION is not recommended for use in pregnant and breastfeeding women. Safety and effectiveness of LATOBEST OPHTHALMIC SOLUTION in prematurely born infants (less than 36 weeks gestation) has not been established yet. The most common side effects of using LATOBEST OPHTHALMIC SOLUTION are problems with the eyes like a gradual change in eye colour and eyelashes, redness, irritation, or pain in the eye. Inform your doctor if any of these symptoms worsen.
LATOBEST OPHTHALMIC SOLUTION works by increasing the natural discharge of fluid (that nourishes the eye) from inside the eye into the bloodstream. Hence decreasing the pressure in the eye.
Use LATOBEST OPHTHALMIC SOLUTION as advised by your physician. It is for ophthalmic use only. Wash your hands before using LATOBEST OPHTHALMIC SOLUTION. Use a finger to gently pull down the lower eyelid to make a pocket of the affected eye. Place one drop into the affected eye(s) and then release the lower eyelid and hold for 1 minute whilst keeping the eye closed.
If you wear contact lenses, remove them before using the eye drops and wait at least 15 minutes before putting them back. Your doctor will decide the right dose and duration depending upon your age, body weight and disease condition.
LATOBEST OPHTHALMIC SOLUTION is not recommended for use in pregnancy, unless considered necessary. Before using LATOBEST OPHTHALMIC SOLUTION inform your doctor if you are pregnant or planning to have a baby.
LATOBEST OPHTHALMIC SOLUTION is not recommended for use in breastfeeding women, unless considered necessary. Before using LATOBEST OPHTHALMIC SOLUTION inform your doctor if you are breastfeeding.
Do not drive or use machines after using LATOBEST OPHTHALMIC SOLUTION if you experience blurred vision.
Do not use LATOBEST OPHTHALMIC SOLUTION if you are allergic to Latanoprost or any other ingredients of this medicine.
LATOBEST OPHTHALMIC SOLUTION should be used with caution if you or your child have severe asthma, or your asthma is not well controlled. Consult your doctor before using it.
Before using LATOBEST OPHTHALMIC SOLUTION, inform your doctor if you or your child:
Use in pediatrics:
LATOBEST OPHTHALMIC SOLUTION has not been studied in prematurely born infants (less than 36 weeks gestation). Consult your doctor before using it.
A. Drug-Drug interactions:
Before using LATOBEST OPHTHALMIC SOLUTION inform your doctor if you are taking any of the following medicine:
Overdosage:
If you or anyone else accidentally use too much of LATOBEST OPHTHALMIC SOLUTION, consult your doctor immediately or visit the nearby hospital. Symptoms of overdose include minor irritation, redness and watery eyes.
| Drug | : | Latanoprost |
| Pharmacological Category | : | Prostaglandin analogue |
| Therapeutic Indication | : | Glaucoma, Ocular hypertension |
| Dosage Forms | : | Eye drops, Ophthalmic solution |
What is LATOBEST OPHTHALMIC SOLUTION used for?
LATOBEST OPHTHALMIC SOLUTION treats high pressure inside the eye. Increased pressure can damage your optic nerve and lead to vision loss or blindness. Your doctor may recommend it to you if you have glaucoma or high pressure in the eye (ocular hypertension).
How does LATOBEST OPHTHALMIC SOLUTION work?
LATOBEST OPHTHALMIC SOLUTION works by increasing the natural discharge of fluid (that nourishes the eye) from inside the eye into the bloodstream. Hence decreasing the pressure in the eye.
Can LATOBEST OPHTHALMIC SOLUTION cause any changes to the eye?
LATOBEST OPHTHALMIC SOLUTION can cause a gradual change in your eye colour. The colour change may be more noticeable if you use this medicine in only one eye. There appears to be no other problems associated with the change in eye colour and, the colour change does not continue after stopping the treatment with LATOBEST OPHTHALMIC SOLUTION.
What is the best time to use LATOBEST OPHTHALMIC SOLUTION?
The best time to use LATOBEST OPHTHALMIC SOLUTION is in the night because it can cause red, sore eyes which will not affect you while you sleep. Consult your doctor before using it.
Can LATOBEST OPHTHALMIC SOLUTION be used in children?
LATOBEST OPHTHALMIC SOLUTION can be used to treat increased eye pressure and glaucoma in all ages of children (from birth to 18 years of age). It is not studied in prematurely born infants (less than 36 weeks gestation), so consult your doctor before using this medicine for your child.
1. Barbara G. Wells, Joseph T. DiPiro, Terry L. Shwinghammer, Cecily V. DiPiro. Glaucoma. Pharmacotherapy handbook. Ninth edition. Page- 665.
2. Albert Alm. Latanoprost in the treatment of glaucoma. NCBI; National Library of Medicine, National Institute of Health. Pubmed Central. September 2014. [Accessed on 10th May 2022] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4196887/
3. Pfizer's Upjohn has merged with Mylan to form Viatris Inc. A Study to Assess the Efficacy of 3 Months of Latanoprost Treatment in Reducing the Intraocular Pressure in Patients with Ocular Hypertension or Open-angle Glaucoma. [Revised in February 2021] [Accessed on 10th May 2022] https://clinicaltrials.gov/ct2/show/NCT00647101
4. Zentiva k.s. Electronic Medicines Compendium (EMC). [Revised in May 2022] [Accessed on 10th May 2022] https://www.medicines.org.uk/emc/files/pil.5974.pdf
5. FDC International Ltd. Electronic Medicines Compendium (EMC). [Revised in May 2022] [Accessed on 10th May 2022] https://www.medicines.org.uk/emc/files/pil.2983.pdf
Written By Dr. Shruthi M R, BDS
Last updated on 13 Jan 2023 | 10:34 AM(IST)